The Anti-Aging Effect of Erythropoietin via the ERK/Nrf2-ARE Pathway in Aging Rats

Journal of Molecular Neuroscience

Volumn 61, Issue 3, 2017, Pages 449-458

  Wu, Haiqin ^a   Zhao, Jiaxin ^b   Chen, Mengyi ^a   Wang, Huqing ^a   Yao, Qingling ^a   Fan, Jiaxin ^a   Zhang, Meng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Anti aging effects; Cu Zn SOD; EPO; ERK; Nrf2; P ERK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COPPER ZINC SUPEROXIDE DISMUTASE; EOSIN; ERYTHROPOIETIN; GALACTOSE; HEMATOXYLIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; FLAVONOID; KEAP1 PROTEIN, RAT; NFE2L2 PROTEIN, RAT; PROTEIN KINASE INHIBITOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LATERAL BRAIN VENTRICLE; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIPPOCAMPUS; MAZE TEST; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HIPPOCAMPUS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; MALE; MAZE LEARNING; MEMORY; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 85011710568     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-017-0885-1     Document Type: Article

References (30)

1. Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Leon R (2016) Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84–104
2. Bundy JD, He J (2016) Hypertension and related cardiovascular disease burden in China. Ann Glob Health 82:227–233
3. Butler RN, Miller RA, Perry D, Carnes BA, Williams TF, Cassel C, Brody J, Bernard MA, Partridge L, Kirkwood T, Martin GM, Olshansky SJ (2008) New model of health promotion and disease prevention for the 21st century. BMJ 337:a399
4. Chetelat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mezenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, Scheltens P, Barkhof F, Rowe CC, Masters CL, de La Sayette V, Bouwman F, Rabinovici GD (2016) Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease. Brain 139:2528–2539
5. Costa LG, Garrick JM, Roque PJ, Pellacani C (2016) Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxidative Med Cell Longev 2016:2986796
6. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641–647
7. Engel PA (2016) Is age-related failure of metabolic reprogramming a principal mediator in idiopathic Parkinson’s disease? Implications for treatment and inverse cancer risk. Med Hypotheses 93:154–160
8. Gassen NC, Chrousos GP, Binder EB, Zannas AS (2016) Life stress, glucocorticoid signaling, and the aging epigenome: implications for aging-related diseases. Neurosci Biobehav Rev
9. Genc K, Egrilmez MY, Genc S (2010) Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells. Cell Biochem Funct 28:197–201
10. Herrera-Arozamena C, Marti-Mari O, Estrada M, de la Fuente Revenga M, Rodriguez-Franco MI (2016) Recent advances in neurogenic small molecules as innovative treatments for neurodegenerative diseases. Molecules 21
11. Jin W, Kong J, Lu T, Wang H, Ni H, Wu J, Dai Y, Jiang J, Liang W (2011) Erythropoietin prevents secondary brain injury induced by cortical lesion in mice: possible involvement of Nrf2 signaling pathway. Ann Clin Lab Sci 41:25–32
12. Juul S (2012) Neuroprotective role of erythropoietin in neonates. J Matern Fetal Neonatal Med 25(Suppl 4):105–107
13. Juul SE, Pet GC (2015) Erythropoietin and neonatal neuroprotection. Clin Perinatol 42:469–481
14. Katsuoka F, Yamamoto M (2016) Small Maf proteins (MafF, MafG, MafK): history, structure and function. Gene 586:197–205
15. Katsuoka F, Motohashi H, Engel JD, Yamamoto M (2005) Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J Biol Chem 280:4483–4490
16. Khalil SK, Amer HA, El Behairy AM, Warda M (2016) Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: molecular and biochemical studies. J Adv Res 7:348–358
17. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM (2005) Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19:2026–2028
18. Koltover VK (2016) Free radical timer of aging: from chemistry of free radicals to systems theory of reliability. Curr Aging Sci
19. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65:1174–1194
20. Kume T, Suenaga A, Izumi Y, Akaike A (2016) Protective effect of dimethyl fumarate on an oxidative stress model induced by sodium nitroprusside in mice. Biol Pharm Bull 39:1055–1059
21. Li YP, Yang GJ, Jin L, Yang HM, Chen J, Chai GS, Wang L (2015) Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta42 in mice. Brain Res 1618:159–167
22. Liochev SI (2015) Which is the most significant cause of aging? Antioxidants (Basel) 4:793–810
23. Lu MC, Ji JA, Jiang ZY, You QD (2016) The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev 36:924–963
24. Merelli A, Czornyj L, Lazarowski A (2013) Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy. Curr Pharm Des 19:6791–6801
25. Merelli A, Czornyj L, Lazarowski A (2015) Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. Int J Neurosci 125:793–797
26. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105–116
27. Sanz A (2016) Mitochondrial reactive oxygen species: do they extend or shorten animal lifespan? Biochim Biophys Acta 1857:1116–1126
28. Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H (2010) Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol 24:573–594
29. Wu H, Wang H, Zhang W, Wei X, Zhao J, Yan P, Liu C (2015) rhEPO affects apoptosis in hippocampus of aging rats by upregulating SIRT1. Int J Clin Exp Pathol 8:6870–6880
30. Zhang DD (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38:769–789